Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 1-5

  Miyauchi, Akira ^a   Futami, Hitoyasu ^b   Hai, Noritaka ^c,d   Yokozawa, Tamotsu ^a   Kuma, Kanji ^a   Aoki, Norihiko ^d   Kosugi, Shinji ^c   Sugano, Kokichi ^e   Yamaguchi, Ken ^b  

^a KUMA HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Germline mutation; Multiple endocrine neoplasia 2B; RET proto oncogene; V804M; Y806C

Indexed keywords

ADULT; ALLELE; ARTICLE; CASE REPORT; CODON; FATHER; FEMALE; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; NEUROFIBROMATOSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID MEDULLARY CARCINOMA;

EID: 0033045514     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00658.x     Document Type: Article

References (20)

1. Mulligan, L. M., Marsh, D. J., Robinson, B. G., Schuffenecker, I., Zedenius, J., Lips, C. J., Gagel, R. F., Takai, S. I., Noll, W. W., Fink, M., Raue, F., Lacroix, A., Thibodeau, S. N., Frilling, A., Ponder, B. A. J. and Eng, C. for the International RET Mutation Consortium. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J. Intern. Med., 238, 343-346 (1995).
2. Schimke, R. N., Hartmann, W. H., Prout, T. W. and Rimoin, D. L. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. N. Engl. J. Med., 279, 1-7 (1968).
3. Gorlin, R. J., Sedano, H. O., Vickers, R. A. and Cervenka, J. Multiple mucosal neuromas, phaeochromocytoma and medullary carcinoma of the thyroid - a syndrome. Cancer, 22, 293-299 (1968).
4. Mulligan, L. M. and Ponder, B. A. J. Genetic basis of endocrine disease. Multiple endocrine neoplasia type 2. J. Clin. Endocrinol. Metab., 80, 1989-1995 (1995).
5. Eng, C., Smith, D. P., Mulligan, L. M., Healey, C. S., Zvelehil, M. J., Stonehouse, T. J., Ponder, M. A., Jackson, C. E., Waterfield, M. D. and Ponder, B. A. J. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene, 10, 509-513 (1995).
6. Bolino, A., Schuffenecker, I., Luo, Y., Seri, M., Silengo, M., Tocco, T., Chabrier, G., Houdent, C., Murat, A., Schlumberger, M., Tourinaire, J., Lenoir, G. M. and Romeo, G. RET mutations in exons 13 and 14 of FMTC patients. Oncogene, 10, 2415-2419 (1995).
7. Fink, M., Weinhasel, A., Niederle, B. and Haas, O. A. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. Int. J. Cancer, 69, 312-316 (1996).
8. Hofstra, R. M. W., Fattoruso, O., Quadro, L., Wu, Y., Libroia, A., Verga, U., Colantuoni, V. and Buys, C. H. C. M. A novel point mutation in the intracellular domain of the RET protooncogene in a family with medullary thyroid carcinoma. J. Clin. Endocrinol. Metab., 82, 4176-4178 (1997).
9. Eng, C., Clayton, D., Schuffernecker, I., Lenoir, G., Cote, G., Gagel, R. F., van Amstel, H. K., Lips, C. J., Nishisho, I., Takai, S., Marsh, D. J., Robinson, B. G., Frank-Raue, K., Raue, F., Xue, F., Noll, W. W., Romei, C., Pacini, F., Fink, M., Niederle, B., Zedenius, J., Nordenskjold, M., Komminoth, P., Hendy, G. N. and Mulligan, L. M. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. JAMA, 276, 1575-1579 (1996).
10. Gimm, O., Marsh, D. J., Andrew, S. D., Frilling, A., Dahia, P. L. M., Mulligan, L. M., Zajac, J. D., Robinson, B. G. and Eng, C. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J. Clin. Endocrinol. Metab., 82, 3902-3904 (1997).
11. Smith, D. P., Houghton, C. and Ponder, B. A. J. Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene, 15, 1213-1217 (1997).
12. Egawa, S., Futami, H., Takasaki, K., Iihara, M., Okamoto, T., Kanbe, M., Ohi, T., Saio, Y., Miyauchi, A., Takiyama, Y., Koga, M., Miyanaga, K., Inoue, K., Mitsuyama, S., Nomura, Y., Takei, H., Mugiya, S., Ishida, O., Zeze, F., Shukutsui, S., Inoue, H., Oya, H., Yoshimura, A., Ishizuka, S., Tsujino, T., Obara, T. and Yamaguchi, K. Genotype-phenotype correlation of the patients with multiple endocrine neoplasia type 2 in Japan. Jpn. J. Clin. Oncol., 28, 590-596 (1998).
13. Ceccherini, I., Hofstra, R. M. W., Luo, Y., Stulp, R. P., Baronc, V., Stelwagen, T., Bocciardi, R., Nijveen, H., Bolino, A., Seri, M., Ronchetto, P., Pasini, B., Bozzano, M., Buys, C. H. C. M. and Romeo, G. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene, 9, 3025-3029 (1994).
14. Uchino, S., Noguchi, S., Adachi, M., Sato, M., Yamashita, H., Watanabe, S., Murakami, T., Toda, M., Murakami, N. and Yamashita, H. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas. Jpn. J. Cancer Res., 89, 411-418 (1998).
15. Scurini, C., Quadro, L., Fattoruso, O., Verga, U., Livroia, A., Lupoli, G., Cascone, E., Marzano, L., Paracchi, S., Busnardo, B., Girelli, M. E., Bellastella, A. and Colantuoni, V. Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas. Mol. Cell Endocrinol., 137, 51-57 (1998).
16. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H. and Fiole, P. P. D. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science, 267, 381-383 (1995).
17. Pasini, A., Geneste, O., Legrand, P., Schlumberger, M., Rossel, M., Fournier, L., Rudkin, B. B., Schuffenecker, I., Lenoir, G. M. and Billaud, M. Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain. Oncngene, 15, 393-402 (1997).
18. Carlson, K. M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A., Jr., Goodfellow, P. J. and Donis-Keller, H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. USA, 91, 1579-1583 (1994).
19. Marsh, D. J., Andrew, S. D., Eng, C., Learoyd, D. L., Capes, A. G., Pojer, R., Richardson, A. L., Houghton, C., Mulligan, L. M., Ponder, B. A. J. and Robinson, B. G. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma. Cancer Res., 56, 1241-1243 (1996).
20. Miyauchi, A., Egawa, S., Futami, H., Kuma, K., Obara, T. and Yamaguchi, K. A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation. Jpn. J. Cancer Res., 88, 527-531 (1997).